Skip to main content
. 2016 Nov 18;11(11):e0163809. doi: 10.1371/journal.pone.0163809

Table 2. Overall survival and median survival of 1522 lung cancer patients stratified by treatment interval from surgery to chemotherapy.

Characteristic Group 1(n = 153) Group 2(n = 261) Group 3(n = 290) Group 4(n = 818) p
Overall survival rate <0.0001
 One-year 0.88 (0.82–0.92) 0.88 (0.84–0.92) 0.87 (0.83–0.91) 0.80 (0.77–0.83)
 Three-year 0.57 (0.48–0.64) 0.64 (0.58–0.70) 0.65 (0.58–0.70) 0.50 (0.46–0.53)
 Five-year 0.41 (0.31–0.5) 0.48 (0.41–0.55) 0.50 (0.43–0.57) 0.35 (0.31–0.39)
Median survival (months) 44.50 (34.70–61.30) 59.53 (44.63–86.06) 67.33 (50.33–76.83) 36.33 (32.17–42.77) <0.0001